Meredith A L, Huson S M, Lunt P W, Sarfarazi M, Harley H G, Brook J D, Shaw D J, Harper P S
Br Med J (Clin Res Ed). 1986 Nov 22;293(6558):1353-6. doi: 10.1136/bmj.293.6558.1353.
The close genetic linkage between the loci for apolipoprotein CII (ApoC2) and myotonic dystrophy makes ApoC2 the closest fully validated marker for prediction of myotonic dystrophy. Application to genetic counselling and presymptomatic and prenatal prediction is reported in seven families with myotonic dystrophy, including one case in which the disorder was excluded prenatally. Only one of the families did not have members with ApoC2 genotypes that allowed prediction, but careful clinical study of older family members was found to be an important factor. ApoC2 typing of families with myotonic dystrophy should be of practical help both in prediction for asymptomatic relatives and for prenatal diagnosis in pregnancies of an affected parent.
载脂蛋白CII(ApoC2)基因座与强直性肌营养不良之间存在紧密的遗传连锁关系,这使得ApoC2成为预测强直性肌营养不良最可靠的已充分验证的标志物。本文报道了ApoC2在7个强直性肌营养不良家系的遗传咨询、症状前及产前预测中的应用情况,其中1例在产前排除了该疾病。只有1个家系没有携带可用于预测的ApoC2基因型成员,但对老年家族成员进行仔细的临床研究被证明是一个重要因素。对强直性肌营养不良家系进行ApoC2分型,对于预测无症状亲属以及患病父母妊娠时的产前诊断均具有实际帮助。